DDInter1082 DDInter374
Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type II diabetes mellitus (T2DM). It is sold by Sanofi-Aventis under the brand name Adlyxin in the US and Lyxumia in the EU. Adlyxin recieved FDA approval July 28, 2016.
Chromium picolinate has a chemical formula CrPic3 and reddish-pink color. It is a coordination complex consisting of chromium(III) and picolinic acid. Chromium picolinate is used as a nutritional supplement for optimal insulin function in patients with Type 2 diabetes or promotion of weight loss. Chromium ions are shown to regulate insulin by promoting glucose utilization and increasing the sensitivity of the insulin receptor .
Chromium picolinate {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Glimepiride
Chromium picolinate {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Semaglutide
Chromium picolinate may cause a moderate interaction that could exacerbate diseases when taken with Glimepiride
Chromium picolinate may cause a moderate interaction that could exacerbate diseases when taken with Semaglutide